• Natálie Klubíčková, Bc, MD
    Natálie Klubíčková, Bc, MD, PhD

    consultant

List of publications

  1. Klubíčková N, Kinkor Z, Michal M, Baněčková M, Hájková V, Michálek J, Pink R, Dvořák Z, Michal M, Leivo I, Skálová A. Epithelioid soft tissue neoplasm of the soft palate with a PTCH1-GLI1 fusion: A case report and review of the literature. Head Neck Pathol. 2022 Jun;16(2):621-630.
  2. Skálová A, Baněčková M, Laco J, Di Palma S, Agaimy A, Ptáková N, Costes-Martineau V, Petersson BF, van den Hout MFCM, de Rezende G, Klubíčková N, Koblížek M, Koshyk O, Vaneček T, Leivo I. Sclerosing polycystic adenoma of salivary glands: A novel neoplasm characterized by PI3K-AKT pathway alterations – New insights into a challenging entity. Am J Surg Pathol. 2022 Feb 1;46(2):268-280.
  3. Lenz J, Klubíčková N, Ptáková N, Hájková V, Grossmann P, Šteiner P, Kinkor Z, Švajdler M, Michal M, Konečná P, Macháčová D, Hurník P, Tichý M, Tichý F, Kyllar M, Fiala L, Kavka M, Michal M. Extraskeletal myxoid chondrosarcoma: A study of 17 cases focusing on the diagnostic utility of INSM1 expression and presenting rare morphological variants associated with non-EWSR1::NR4A3 fusions. Hum Pathol. 2022 Dec 20:S0046-8177(22)00283-0.
  4. Klubíčková N, Agaimy A, Hájková V, Ptáková N, Grossmann P, Šteiner P, Michal M, Michal M. RNA-sequencing of myxoinflammatory fibroblastic sarcomas reveals a novel SND1::BRAF fusion and 3 different molecular aberrations with the potential to upregulate the TEAD1 gene including SEC23IP::VGLL3 and TEAD1::MRTFB gene fusions. Virchows Arch. 2022 Oct;481(4):613-620.
  5. Klubíčková N, Michal M, Agaimy A, Zidar N, Pavlovský M, Yorita K, Grossmann P, Hájková V, Ptáková N, Šteiner P, Michal M. TIMP3::ALK fusions characterize a distinctive myxoid fibroblastic tumor of the vocal cords: A report of 7 cases. Virchows Arch. 2022 Nov;481(5):721-729.
  6. Meyer A, Klubíčková N, Mosaieby E, Grossmann P, Kalmykova A, Koshyk O, Michal M. Biphenotypic sinonasal sarcoma with PAX3::MAML3 fusion transforming into high-grade rhabdomyosarcoma: Report of an emerging rare phenomenon. Virchows Arch. 2023 Jan 31. doi: 10.1007/s00428-023-03501-0. Epub ahead of print.
  7. Michal M, Ud Din N, Švajdler M, Klubíčková N, Ptáková N, Hájková V, Michal M, Agaimy A. TFG::MET-rearranged soft tissue tumor: A rare infantile neoplasm with a distinct low-grade triphasic morphology. Genes Chromosomes Cancer. 2023 May;62(5):290-296.
  8. Klubíčková N, Grossmann P, Šteiner P, Baněčková M, Mosaieby E, Koshyk O, Michal M, Leivo I, Skálová A. A minority of cases of acinic cell carcinoma of the salivary glands are driven by an NR4A2 rearrangement: The diagnostic utility of the assessment of NR4A2 and NR4A3 alterations in salivary gland tumors. Virchows Arch. 2023 Feb;482(2):339-345.

Lectures

  1. Sklíčkový seminář patologických pracovišť, 30.9.-1.10.2021, Lednice:
    Přednáška: Tumor hlasivky s TIMP3::ALK fúzí.
  2. 34th European Congress of Pathology, 3-7.9.2022, Basilej:
    Přednáška 1: A single-institution experience with 128 cases of acinic cell carcinoma: diagnostic utility of NR4A3 and NR4A2 immunohistochemistry in salivary glands pathology,
    Přednáška 2: A single institution experience with 17 cases of extraskeletal myxoid chondrosarcoma: rare fusion, unusual morphology and the utility of INSM1 immunohistochemistry.
  3. 47. Sjezd českých patologů, 3.-5.11.2022, Praha:
    Přednáška: Tumory s diferenciací do příčně pruhované svaloviny: přehled novinek a diferenciální diagnostika.
  4. Sklíčkový seminář patologických pracovišť, 10.-11.11.2022, Mikulov:
    Přednáška 1: Novinky v mezenchymálních lézích s diferenciací do příčně pruhované svaloviny,
    Přednáška 2: Hyalinizující světlobuněčný karcinom slinné žlázy rtu s fúzí SMARCA2::CREM, Přednáška 3: Sinonasální solitární fibrózní tumor.

Posters

  1. 111th USCAP, 19.-24.3.2022, Los Angeles, CA, USA:
    Poster 1: Targeted DNA and RNA sequencing of soft tissue spindle cell tumors reveals a rare MET::TFG and a novel PWWP2A::RET gene fusions as well as additional recurrent PIK3CA point mutations,
    Poster 2: Solitary fibrous tumor with pure round cell morphology: immunohistochemical and molecular study of 15 cases.
  2. 112th USCAP, 11.-16.3.2023, New Orleans, LA, USA:
    Poster 1: Targeted RNA sequencing of ossifying fibromyxoid tumors reveals novel PHF1 gene fusions and unusual morphologic features,
    Poster 2: SMARCB1-deficient sinonasal adenocarcinoma: Rare variant of SWI/SNF-deficient malignancy often misclassified as high-grade non-intestinal adenocarcinoma or myoepithelial carcinoma